4th Quarter - Report

SAREPTA THERAPEUTICS, INC. for SAREPTA THERAPEUTICS, INC.

Firm
Client
Income
—
Expenses
$240,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to patient access to treatments Issues related to rare diseases Issues related to newborn screening Issues related to scientific innovation in healthcare Public Law 117-169, Inflation Reduction Act of 2022; Provisions related to prescription drugs

LobbyistCovered position, as disclosed
KIP PAYNE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Tax issues related to research and development

LobbyistCovered position, as disclosed
KIP PAYNE New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.